physical disease or drug abuse. There was no family history of any psychiatric illness.
Mental state examination revealed no perceptual abnormality. He was anxious. Thinking revealed the presence of delusions of insect repeatedly crawling over his lower limbs. No other psychopathology was detected. Higher mental functions were normal.
The patient was explained the treatment options available. He was also told that an antipsychotic pimozide was the most accepted treatment for this disorder but was explained the need for regular cardiac monitoring to which he refused. He was given options of using atypical antipsychotics, most of which have shown efficacy in this condition. The patient was started on 2 mg of risperidone but could not tolerate it because of excessive sedation. The patient reported features of akathisia on 10 mg of aripiprazole. He conveyed an inability to afford amisulpride. Due to all these issues, after discussion, he was started on tablet blonanserin 4 mg/day (in divided doses), which was increased to 8 mg/day after 2 weeks and tablet lorazepam 2 mg at night for sleep (on SOS basis). There was partial improvement after 4 weeks of treatment. The dose was further increased to 12 mg/day after 4 weeks. There was complete remission of the patient's delusion at 6 weeks of treatment. On following him up at 3 months, he did not develop the delusion again.
The exact mechanism of this disorder is not known. One hypothesis is that these patients suffer a profound breakdown in their ability to discriminate between normal and abnormal somatic perceptions and the delusion may be mediated by a pathological overactivity of the dopaminergic system. There are reports mentioning the usefulness of second-generation antipsychotics in the treatment of delusional parasitosis. [2, 4, 5] Blonanserin is used for the treatment of schizophrenia and has not been tried in the treatment of delusional infestation. The present case responded completely to blonanserin.
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Uncommon manifestations of Vitamin B 12 deficiency
Sir, Vitamin B 12 (vitB 12 ) deficiency is known to cause symptoms related to all the systems of human body. We present here a patient of vitB 12 deficiency with rare combination of acute exacerbation of psychiatric manifestations, brain atrophy, severe anemia with coronary insufficiency, and premature graying of hair, all of which disappeared with VitB 12 plays an important role in DNA synthesis. Its deficiency is associated with hematologic, neurologic, psychiatric, gastrointestinal, dermatologic, and cardiovascular manifestations. [1, 2] The vitamin is involved in the proliferation, maturation, and regeneration of neural cells. [3] Hence, cognitive dysfunction may be a manifestation of cortical neuronal dysfunction. Deficiency of cyanocobalamin leads to accumulation of methylmalonyl-CoA and homocysteine in the serum, [2] which are risk factors for coronary artery disease. Cyanocobalamin deficiency characteristically produces a megaloblastic picture in peripheral smear. [2, 3] Probably, there is a window period, when vitB 12 therapy can reverse the changes both in subacute degeneration of spinal cord and cognitive dysfunction. [4, 5] Total vitB 12 estimation is cost-effective. [6] However, serum MMA is a functional marker and a lower level of serum holotranscobalamin is the earliest marker of vitB 12 deficiency. [3, 6] They are sensitive and specific but costly. In our country, many big cities do not have laboratory facilities to estimate serum level of total vitB 12 and folic acid, so, we suggest, peripheral smear showing evidence of megaloblastic changes and symptoms of vitB 12 deficiency should prompt the clinician to start treatment with parenteral vitB 12 to prevent irreversible neuropsychiatric changes, however blood sample may be collected for vitB 12 and folic acid estimation before that.
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A 55-year-old man presented in our outpatient department, with complaints of irrelevant talk for 10 days. Fifteen days back, while he was visiting his psychiatrist, he collapsed in front of the clinic, so was referred to the emergency department. He was advised coronary angiogram by the cardiologist as there was evidence of coronary insufficiency in his electrocardiogram. In the meantime, the patient developed irrelevant talk and impaired judgment for which he was referred to us to rule out organic causes.
The patient was being treated for anxiety and depression for the past 3 years and was on sertraline hydrochloride, olanzapine, and phenergan at the time of presentation before us. He was apathetic, of average built, pale, unshaven, and sick looking. His hair on the face and head was gray [ Figure 1 ]. His memory was disturbed, judgment impaired, had a changed personality as he had become isolated, apathetic, and withdrawn. He was also unwilling to think and depressed. His peripheral smear showed megaloblastic changes. His hemoglobin was 6 g%, total and platelet count were 3400 and 120,000/cubic millimeter of blood, respectively. His biochemical parameters were within normal limit. Computed tomography (CT) scan of his brain showed atrophy of the brain. His blood was sent for vitB 12 and folic acid estimation, and he was started with vitB 12 1000 microgram intramuscularly once daily and olanzapine 5 mg at bedtime. His serum VitB 12 and folic acid value came to be 90 pg and 10 ng/ ml, respectively. His weakness improved significantly with immediate effect, all other symptoms took around 1 month to improve. At the end of 1-year, his CT scan of brain, hematological and biochemical parameters became normal. 
